Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Compare Pharmacokinetic (PK) Profiles of Naproxen Sodium, Diphenhydramine Hydrochloride, and Naproxen Sodium and Diphenhydramine Hydrochloride Combination (Morpheus PK)

This study has been completed.
Information provided by (Responsible Party):
Bayer Identifier:
First received: August 14, 2012
Last updated: August 20, 2014
Last verified: August 2014
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2012
  Primary Completion Date: February 2012 (Final data collection date for primary outcome measure)